PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $7,924 | -31.3% | 1,495 | -60.0% | 0.00% | – |
Q1 2023 | $11,535 | -23.1% | 3,733 | -22.1% | 0.00% | – |
Q4 2021 | $15,000 | +400.0% | 4,789 | +908.2% | 0.00% | – |
Q3 2021 | $3,000 | -50.0% | 475 | -24.7% | 0.00% | – |
Q2 2021 | $6,000 | -45.5% | 631 | -42.6% | 0.00% | – |
Q1 2021 | $11,000 | -96.4% | 1,100 | -96.3% | 0.00% | -100.0% |
Q4 2020 | $307,000 | -12.5% | 29,896 | -14.0% | 0.00% | 0.0% |
Q3 2020 | $351,000 | +47.5% | 34,772 | +52.1% | 0.00% | 0.0% |
Q2 2020 | $238,000 | -56.5% | 22,858 | -64.7% | 0.00% | -75.0% |
Q1 2020 | $547,000 | -20.3% | 64,825 | -17.3% | 0.00% | -20.0% |
Q4 2019 | $686,000 | +1125.0% | 78,432 | +2747.9% | 0.01% | – |
Q4 2018 | $56,000 | -95.4% | 2,754 | -89.7% | 0.00% | -100.0% |
Q3 2018 | $1,223,000 | -31.1% | 26,674 | -11.1% | 0.01% | -33.3% |
Q2 2018 | $1,774,000 | -40.3% | 29,993 | -31.4% | 0.02% | -50.0% |
Q1 2018 | $2,974,000 | -18.7% | 43,705 | +18.1% | 0.03% | +15.4% |
Q4 2017 | $3,659,000 | -16.7% | 37,012 | -26.4% | 0.03% | -43.5% |
Q2 2017 | $4,393,000 | +204.6% | 50,263 | +29.6% | 0.05% | +170.6% |
Q1 2017 | $1,442,000 | +63.5% | 38,771 | +35.0% | 0.02% | +88.9% |
Q4 2016 | $882,000 | +1016.5% | 28,729 | +985.8% | 0.01% | +800.0% |
Q2 2016 | $79,000 | -65.9% | 2,646 | -66.5% | 0.00% | -66.7% |
Q1 2016 | $232,000 | -17.7% | 7,907 | +119.8% | 0.00% | 0.0% |
Q4 2015 | $282,000 | -87.1% | 3,598 | -87.6% | 0.00% | -90.0% |
Q3 2015 | $2,188,000 | +0.7% | 29,039 | +56.0% | 0.03% | 0.0% |
Q2 2015 | $2,173,000 | +50.7% | 18,612 | +207.9% | 0.03% | +36.4% |
Q3 2014 | $1,442,000 | +40.0% | 6,045 | -61.3% | 0.02% | +37.5% |
Q2 2014 | $1,030,000 | +31.0% | 15,601 | +106.8% | 0.02% | +23.1% |
Q1 2014 | $786,000 | +5946.2% | 7,545 | +2918.0% | 0.01% | – |
Q3 2013 | $13,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |